Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

488
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
488
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

403
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
403
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DYRK1A Signaling in the Brain: Molecular Mechanisms and Neurotransmitter Regulation.

Current neurovascular research·2026
Same author

In Silico Prediction, Characterization, and Pre-clinical Appraisal of the Neuroprotective Effect of the Methanolic Extract of Cassytha filiformis.

Current neurovascular research·2026
Same author

Therapeutic Potential of a Phytochemical-rich Herbal Formulation (Ezenus) in the Modulation of Stress and Anxiety-related Behaviors: Evidence from Preclinical Models.

Current neurovascular research·2026
Same author

Therapeutic Potential of Natural Chalcones Against Alzheimer's Disease: A Mechanistic Insight.

Current neurovascular research·2026
Same author

Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions.

Reviews on recent clinical trials·2026
Same author

Phosphodiesterase-5 Inhibitors in Neurodegenerative Diseases: A Path to Cognitive Rescue.

Current protein & peptide science·2026

相关实验视频

Updated: May 27, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K

革新药物开发:在制药科学中利用人工智能

Samaresh Pal Roy1, Sunil Kumar Kadiri2, Suchismita Bhowmik3

  • 1School of Pharmacy, P P Savani University, NH 8, GETCO, Near Biltech, Dhamdod, Kosamba, Surat, Gujarat, 394125, India.

Current drug discovery technologies
|February 17, 2025
PubMed
概括

人工智能 (AI) 正在改变制药科学,加速药物发现和个性化医疗. 克服数据,监管和道德挑战是实现人工智能在医疗保健中的全部潜力的关键.

关键词:
人工智能挑战的人工智能挑战人工智能的人工智能是人工智能.发现药物的发现.医疗保健的影响.个性化医疗是个性化的医疗.制药科学 制药科学 制药科学技术的进步技术的进步

更多相关视频

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

相关实验视频

Last Updated: May 27, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

科学领域:

  • 制药科学 制药科学
  • 生物技术是生物技术.
  • 计算化学计算化学

背景情况:

  • 人工智能 (AI) 的整合代表了制药科学的重大进步.
  • 人工智能为药物发现和开发中的创造力和生产力提供了新的机会.
  • 当代制药实践越来越多地将人工智能纳入各种阶段.

研究的目的:

  • 为制药科学中人工智能应用提供全面的分析.
  • 概述最近的进展,并探索人工智能技术在该领域的未来发展轨迹.
  • 确定人工智能在药物开发中的整合挑战和机会.

主要方法:

  • 审查当前的人工智能技术及其在药物发现中的应用.
  • 对人工智能在个性化医疗和药物开发管道中的作用的分析.
  • 探索人工智能实施的数据质量,监管和伦理考虑.

主要成果:

  • 人工智能在药物开发方面取得了重大进展,降低了成本,提高了有效性和安全性.
  • 人工智能应用跨越多个阶段,从初步发现到个性化治疗策略.
  • 人工智能的进步已经证明了更多个性化和高效的医疗保健解决方案的潜力.

结论:

  • 利用人工智能的潜力需要解决诸如数据质量,监管障碍和道德考虑等挑战.
  • 人工智能驱动的战略将通过提高个性化和效率来彻底改变医疗保健.
  • 利益相关者需要指导,以了解和利用药物科学中的AI,以改善患者的治疗结果.